tangomed logo

TangoMed | Integrated Clinical Research & Language Science Partner

Solutions
April 06, 2026
HTML/CSS/JAVASCRIPT Personalizado
Integrated Clinical ResearchLanguage Science Patient SafetyClinical Trial IntegrityLinguistic ValidationPatient Recruitment StrategyHealth Literacy ICFClinical Research Risk Management
Laura Rolfi is the CEO of Sharpline Life Sciences, a key partner in the TangoMed integrated clinical research solution. With a deep commitment to excellence in the pharmaceutical and biotech industries, Laura leads initiatives that bridge the gap between complex clinical requirements and operational success.Under her leadership, Sharpline collaborates with TangoMed to redefine how language is viewed in the research lifecycle—not just as a translation task, but as critical infrastructure that drives trial integrity, efficiency, and, most importantly, patient safety

Laura Rolfi

Laura Rolfi is the CEO of Sharpline Life Sciences, a key partner in the TangoMed integrated clinical research solution. With a deep commitment to excellence in the pharmaceutical and biotech industries, Laura leads initiatives that bridge the gap between complex clinical requirements and operational success.Under her leadership, Sharpline collaborates with TangoMed to redefine how language is viewed in the research lifecycle—not just as a translation task, but as critical infrastructure that drives trial integrity, efficiency, and, most importantly, patient safety

Back to Blog